Literature DB >> 28571906

Limited Utility of Pulmonary Nodule Risk Calculators for Managing Large Nodules.

Mark M Hammer1, Arun C Nachiappan2, Eduardo J Mortani Barbosa3.   

Abstract

RATIONALE AND
OBJECTIVES: The optimal management of large pulmonary nodules, at higher risk for lung cancer, has not been determined, and it remains unclear as to which patients should undergo follow-up imaging vs invasive tissue diagnosis via biopsy or surgical resection.
MATERIALS AND METHODS: Through search of radiology reports, 86 nodules from our institution were identified using the inclusion criterion of solid nodules measuring greater than 8mm. We evaluated these nodules with a number of risk prediction calculators, including the Brock University model, and compared these against the proven diagnosis.
RESULTS: Of 86 nodules, 59 (69%) nodules were malignant. The most accurate predictive model, the Brock University calculator, underestimated the risk for this group at 33%. At its optimal threshold, this model had a positive predictive value of 81% and negative predictive value of 53%. Notwithstanding the low negative predictive value, the positive predictive value was no better than patients clinically selected for biopsy (86% of biopsies were malignant).
CONCLUSION: Existing nodule risk prediction calculators are of limited usage in guiding the management of large pulmonary nodules. At present, the accuracy of these models in this setting is inferior to expert clinical judgment, and future work is needed to develop management algorithms for higher-risk nodules.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28571906     DOI: 10.1067/j.cpradiol.2017.04.003

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN: 0363-0188


  7 in total

1.  Post-imaging pulmonary nodule mathematical prediction models: are they clinically relevant?

Authors:  Johanna Uthoff; Nicholas Koehn; Jared Larson; Samantha K N Dilger; Emily Hammond; Ann Schwartz; Brian Mullan; Rolando Sanchez; Richard M Hoffman; Jessica C Sieren
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

2.  Comparison of Veterans Affairs, Mayo, Brock classification models and radiologist diagnosis for classifying the malignancy of pulmonary nodules in Chinese clinical population.

Authors:  Xiaonan Cui; Marjolein A Heuvelmans; Daiwei Han; Yingru Zhao; Shuxuan Fan; Sunyi Zheng; Grigory Sidorenkov; Harry J M Groen; Monique D Dorrius; Matthijs Oudkerk; Geertruida H de Bock; Rozemarijn Vliegenthart; Zhaoxiang Ye
Journal:  Transl Lung Cancer Res       Date:  2019-10

3.  Cost-Effectiveness of Management Algorithms for Lung-RADS Category 4 Nodules.

Authors:  Mark M Hammer; Sumit Gupta; Chung Yin Kong
Journal:  Radiol Cardiothorac Imaging       Date:  2021-04-15

Review 4.  Implications of the updated Lung CT Screening Reporting and Data System (Lung-RADS version 1.1) for lung cancer screening.

Authors:  Spencer C Dyer; Brian J Bartholmai; Chi Wan Koo
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

5.  A simple assessment of lung nodule location for reduction in unnecessary invasive procedures.

Authors:  C Matthew Kinsey; Ehab Billatos; Vitor Mori; Ben Tonelli; Bernard F Cole; Fenghai Duan; Helga Marques; Isaac de la Bruere; Jorge Onieva; Rubén San José Estépar; Alyx Cleveland; Dan Idelkope; Chris Stevenson; Jason H T Bates; Denise Aberle; Avi Spira; George Washko; Raúl San José Estépar
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 3.005

6.  Noninvasive pulmonary nodule characterization using transcutaneous bioconductance: Preliminary results of an observational study.

Authors:  Joanna Gariani; Steve P Martin; Anne-Lise Hachulla; Wolfram Karenovics; Dan Adler; Paola M Soccal; Chirstoph D Becker; Xavier Montet
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

7.  Solitary pulmonary nodule malignancy predictive models applicable to routine clinical practice: a systematic review.

Authors:  Marina Senent-Valero; Julián Librero; María Pastor-Valero
Journal:  Syst Rev       Date:  2021-12-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.